Safety and immunogenicity of a novel multiple antigen pneumococcal vaccine in adults: A Phase 1 randomised clinical trial
- 1 December 2017
- journal article
- research article
- Published by Elsevier BV in Vaccine
- Vol. 35 (51), 7181-7186
- https://doi.org/10.1016/j.vaccine.2017.10.076
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Invasive pneumococcal disease in children aged younger than 5 years in India: a surveillance studyThe Lancet Infectious Diseases, 2017
- Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite, population-based surveillanceThe Lancet Infectious Diseases, 2015
- Adjuvant system AS02V enhances humoral and cellular immune responses to pneumococcal protein PhtD vaccine in healthy young and older adults: Randomised, controlled trialsVaccine, 2015
- Distribution of Serotypes, Vaccine Coverage, and Antimicrobial Susceptibility Pattern of Streptococcus Pneumoniae in Children Living in SAARC Countries: A Systematic ReviewPLOS ONE, 2014
- Safety and immunogenicity of an investigational vaccine containing two common pneumococcal proteins in toddlers: A phase II randomized clinical trialVaccine, 2014
- Impact of pneumococcal conjugate vaccines on nasopharyngeal carriage and invasive disease among unvaccinated people: Review of evidence on indirect effectsVaccine, 2013
- Serotype-Specific Changes in Invasive Pneumococcal Disease after Pneumococcal Conjugate Vaccine Introduction: A Pooled Analysis of Multiple Surveillance SitesPLoS Medicine, 2013
- Making new vaccines affordable: a comparison of financing processes used to develop and deploy new meningococcal and pneumococcal conjugate vaccinesThe Lancet, 2011
- Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimatesThe Lancet, 2009
- Pneumolysin: A Double-Edged Sword During the Host-Pathogen InteractionCurrent Molecular Medicine, 2008